Arcturus Therapeutics Holdings Inc. financial data

Symbol
ARCT on Nasdaq
Industry
Pharmaceutical Preparations
Location
10628 Science Center Drive, Suite 250, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
Mar 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 397 % -12.5%
Debt-to-equity 48.5 % -7.68%
Return On Equity -31.6 % -212%
Return On Assets -21.3 % -220%
Operating Margin -62.8 % -34%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.1M shares +0.76%
Common Stock, Shares, Outstanding 27M shares +0.64%
Entity Public Float 603M USD -13%
Common Stock, Value, Issued 27K USD 0%
Weighted Average Number of Shares Outstanding, Basic 27M shares +1.4%
Weighted Average Number of Shares Outstanding, Diluted 27M shares +1.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 152M USD -8.69%
Research and Development Expense 195M USD +1.57%
General and Administrative Expense 52.8M USD -0.09%
Operating Income (Loss) -95.7M USD -22.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -80.9M USD -190%
Income Tax Expense (Benefit) -4K USD -100%
Net Income (Loss) Attributable to Parent -80.9M USD -172%
Earnings Per Share, Basic -3 USD/shares -168%
Earnings Per Share, Diluted -3 USD/shares -168%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 237M USD -18.8%
Accounts Receivable, after Allowance for Credit Loss, Current 3.97M USD -87.6%
Assets, Current 306M USD -20.9%
Property, Plant and Equipment, Net 9.53M USD -23.3%
Operating Lease, Right-of-Use Asset 26.7M USD -6.41%
Assets 344M USD -19.9%
Accounts Payable, Current 7.19M USD +36.3%
Employee-related Liabilities, Current 13.3M USD +125%
Accrued Liabilities, Current 38.8M USD +21.6%
Liabilities, Current 65.5M USD -20.1%
Operating Lease, Liability, Noncurrent 25M USD -3.51%
Other Liabilities, Noncurrent 497K USD -82.3%
Liabilities 103M USD -31.7%
Retained Earnings (Accumulated Deficit) -449M USD -22%
Stockholders' Equity Attributable to Parent 241M USD -13.5%
Liabilities and Equity 344M USD -19.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.56M USD +84.5%
Net Cash Provided by (Used in) Financing Activities 2.19M USD
Net Cash Provided by (Used in) Investing Activities -240K USD +65.3%
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 27M shares +0.64%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.61M USD +94.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 294M USD -15.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.1M USD +1144%
Deferred Tax Assets, Valuation Allowance 138M USD +26.9%
Deferred Tax Assets, Gross 145M USD +24.2%
Operating Lease, Liability 28.6M USD -5.51%
Payments to Acquire Property, Plant, and Equipment 240K USD -65.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -80.9M USD -172%
Lessee, Operating Lease, Liability, to be Paid 33.8M USD -7.56%
Property, Plant and Equipment, Gross 21.3M USD +0.83%
Operating Lease, Liability, Current 3.55M USD -17.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.27M USD +31.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.81M USD -14.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.24M USD -17.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.13M USD +14.7%
Deferred Tax Assets, Operating Loss Carryforwards 25.4M USD +32.7%
Unrecognized Tax Benefits 6.8M USD +88.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.82M USD +2.99%
Additional Paid in Capital 690M USD +6.72%
Share-based Payment Arrangement, Expense 38M USD +9.64%